Sudarshan Chemical Board Approves Q2 Results & Appoints Amit Deshpande as Company Secretary
Sudarshan Chemical Industries Limited approved its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board also appointed Mr. Amit Deshpande as Company Secretary and Compliance Officer, effective November 6, 2026. The trading window will reopen on November 9, 2026.
The appointment of a Company Secretary and Compliance Officer is a critical governance role. The release of quarterly results is also a material event for investors.
The announcement details routine financial results and a management appointment, which are standard corporate events and do not inherently suggest a positive or negative shift in the company's outlook.
Sudarshan Chemical Industries Limited announced the outcome of its Board Meeting held on November 6, 2026. The Board approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026. The financial results, along with the limited review report from M/s. S R B C & CO LLP, were recommended by the Audit Committee.
In a significant management update, the Board approved the appointment of Mr. Amit Deshpande (ACS:17551) as the Company Secretary, Compliance Officer, Nodal Officer, and Key Managerial Personnel, effective November 6, 2026. This appointment is in addition to his existing roles as General Counsel and Senior Management Personnel. The Board also approved changes in authorization for determining materiality of events and making disclosures, designating Mr. Rajesh Rathi (Chairman and Managing Director), Mr. Ashish Vij (Whole-Time Director), Mr. Nilkanth Natu (Chief Financial Officer), and Mr. Amit Deshpande (General Counsel and Company Secretary) as authorized personnel.
The trading window for dealing in the company's securities will reopen on Monday, November 9, 2026, 48 hours after the declaration of the financial results. The Board meeting commenced at 12:00 p.m. (IST) and concluded at 2:00 p.m. (IST).
What to do with a filing like this
Sudarshan Chemical Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sudarshan Chemical Industries Limited. Read the original for the full detail.